The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Paracrine Signaling by Platelet-Derived Growth Factor-CC Promotes Tumor Growth by Recruitment of Cancer-Associated Fibroblasts
Open accessAbstract
Cancer results from the concerted performance of malignant cells and stromal cells. Cell types populating the microenvironment are enlisted by the tumor to secrete a host of growth-promoting cues, thus upholding tumor initiation and progression. Platelet-derived growth factors (PDGF) support the formation of a prominent tumor stromal compartment by as of yet unidentified molecular effectors. Whereas PDGF-CC induces fibroblast reactivity and fibrosis in a range of tissues, little is known about the function of PDGF-CC in shaping the tumor-stroma interplay. Herein, we present evidence for a paracrine signaling network involving PDGF-CC and PDGF receptor-alpha in malignant melanoma. Expression of PDGFC in a mouse model accelerated tumor growth through recruitment and activation of different subsets of cancer-associated fibroblasts. In seeking the molecular identity of the supporting factors provided by cancer-associated fibroblasts, we made use of antibody arrays and an in vivo coinjection model to identify osteopontin as the effector of the augmented tumor growth induced by PDGF-CC. In conclusion, we establish paracrine signaling by PDGF-CC as a potential drug target to reduce stromal support in malignant melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many of the expanding range of receptor tyrosine kinase inhibitors have some activity on FGF and PDGF receptors that can drive fibroblast function148,149.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [148]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“In addition, in agreement with our studies, and with the notion that the tumor stroma is in many aspects similar to a wound that does not heal (40), an analogous situation was recently described for skin wound healing, during”
ResultOrimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,354
Stromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Ömeroğlu, G., Meterissian, S. H., Ömeroğlu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,707
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Tumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996
Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type
Orimo, A., & Weinberg, R. A. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3112 · Cited by 807
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
Mahadevan, D., & Hoff, D. D. V. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0686 · Cited by 619
Therapeutic targeting of the tumor microenvironment
Joyce, J. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.024 · Cited by 598
The stroma reaction myofibroblast: a key player in the control of tumor cell behavior
Desmoulière, A., Guyot, C., & Gabbiani, G. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041802ad · Cited by 551
Cited by
Sorted by citations
Items 201–249 of 249
Kanzaki, R., Ose, N., Kawamura, T., Funaki, S., Shintani, Y., Minami, M., Takakura, N., & Okumura, M. (2018) · World Journal of Surgery · doi:10.1007/s00268-018-4560-7 · Cited by 2
Thompson, J. (2012) · The Atrium (University of Guelph) · Cited by 1
Cancer Therapeutics: Structure-Based Drug Design of Inhibitors for a Novel Angiogenic Growth Factor
Nambigari, N. (2023) · Mathematical Biology and Bioinformatics · doi:10.17537/2023.18.72 · Cited by 1
Kim, B., Park, K., Hwang, M., Lee, H. W., Park, K.-M., Choe, J., Shin, S. H., Jeong, B., Lee, K., Lee, J. H., et al. (2025) · Cancers · doi:10.3390/cancers17172858 · Cited by 1
Targeting metabolic vulnerabilities with advanced delivery systems
Ye, W., Li, X., Chandra, J., Yu, J., Zhou, T., & Li, Z. (2026) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2026.01.003 · Cited by 2
Self-citationCancer Associated Fibroblasts as Therapeutic Targets
Rupp, C., Dolznig, H., Haslinger, C., Schweifer, N., & Garin‐Chesa, P. (2011) · Springer eBooks · doi:10.1007/978-94-007-0659-0_20 · Cited by 1
Revamping Anticancer Strategies by Modulating Tumor Microenvironment Using Botanicals
Chugh, N., & Koul, A. (2024) · Springer eBooks · doi:10.1007/978-981-99-3746-2_33 · Cited by 1
The Role Of Pdgf C And Its Splice Variant In Breast Cancer
Bottrell, A. (2014) · Human Biology · Cited by 1
Stromal promotion of metastasis by erythroid differentiation regulator 1
Mango, R. L. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/etv1-h445 · Cited by 1
Verginadis, I. I., Avgousti, H., Monslow, J., Skoufos, G., Chinga, F., Leli, N. M., Karagounis, I. V., Bell, B. I., Salinas, C. S., Li, Y., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-122088/v1 · Cited by 1
Natural killer cells in cancer : studies on migration and cytotoxicity
Wennerberg, E. (2014) · Figshare
Analyses of Akt and PDGF receptor expression and activation in human tumors
Paulsson, J. (2009) · Figshare
PDGFB AND P53 IN BRAIN TUMORIGENESIS
Hede, S. (2010) · Figshare
Stromal Cells and Tumor Milieu: PDGF et al.
Jacob, M., & Puré, E. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0711-0_14
Holmlund, C. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Exploring novel roles of tumor pericytes
Hong, J. W. (2015) · Figshare
Platelet-derived growth factor
Östman, A., & Heldin, C. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.014
Targeting the PDGF signaling pathway in tumor
Heldin, C. (2013)
Roles of the ING1 Epigenetic Regulator in Breast Cancer
Thakur, S. S. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27691
Wang, T., Yun, S. J., & Xu, X. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3554-3_1
Tumorőssejtek szerepe a melanoma progressziójában és heterogenitásában
Széky, B., Silló, P., Fábián, M., Mayer, B., Kárpáti, S., & Németh, K. (2016) · Orvosi Hetilap · doi:10.1556/650.2016.30487
Stroma and vessel characteristics in cancer : impact on prognosis and response to treatment
Mezheyeuski, A. (2016) · Figshare
The role of fibroblasts in cancer progression, therapy resistance and field cancerization
Chan, J. S. K. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72335
Stromal PDGF Receptors as Prognostic and Predictive Biomarkers
Östman, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-39147-2_5
Lei, X., Liang, Y., Chen, J., Xiao, S., Lei, J., Li, J., Duanmu, J., Jiang, Q., Liu, D., Tang, C. W., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29892-8
RetractedMacGregor, H. L. (2020) · TSpace (University of Toronto)
Timpson, P. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737260944.793580089
Adipose Tissue-Derived Progenitor Cells and Cancer
Tseng, C., & Kolonin, M. G. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8069-3_15
El‐Deiry, W. S., & Ralff, M. D. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732830245.793546323
Stromal PDGF Receptors; Impact on Prognosis and Response to Treatment
Strell, C., & Östman, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_8
A novel molecular imaging probe 99m Tc-HYNIC-FAPI targeting cancer- associated fibroblastsPreprint
Jiang, Y., Tian, Y., Feng, B., Zhao, T., Du, L., Yu, X., & Zhao, Q. (2022) · Research Square · doi:10.21203/rs.3.rs-2222626/v1
Intra-Tumor Cell Heterogeneity: Different Immune Responses for Different Cells
Roerden, M., & Lengerke, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_40-1
Liang, D., Meyer, L. A., Chang, D. W., Lin, J., Pu, X., Ye, Y., Gu, J. H., Wu, X., & Lu, K. H. (2023) · doi:10.1158/0008-5472.c.6500874
Intra-tumor Cell Heterogeneity: Different Immune Responses for Different Cells
Roerden, M., & Lengerke, C. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_40
Yi, H., Liu, H.-H., Ding, J.-T., Zhou, H.-N., Huang, H.-Y., Liu, J., Huang, Y.-F., Taicheng, Z., & Zong, Z. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e43767
Suzuki, R., Watanabe, S., Shono, K., MASUDA, T., Yanai, K., Yamazaki, R., Ando, Y., Wakabayashi, T., Tanaka, S., Sekiya, T., et al. (2026) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-026-04350-x
Role of stroma and Wound Healing in carcinoma response to ionizing radiation
Arshad, A. (2014) · theses.fr (ABES) · doi:10.70675/64b07d78z5f57z479ezb5e7za4825a30617d
Implication de Nanos-3 dans l’invasion tumorale broncho-pulmonaire
Grelet, S. (2014) · theses.fr (ABES) · doi:10.70675/9e0956d3z4c48z4e5dza8b1z287297610fb0
Louault, K. (2018) · theses.fr (ABES) · doi:10.70675/0aef1137z5689z4922z8455zdbe4b757612c
Chen, R., Lu, W., Zhu, J., Huang, L., Chen, W., Huang, G., Ren, X., Sun, Q., Hu, J., Li, J., et al. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.5.36
Self-citationCong, X., Zhang, X., Yang, H., Zhao, Q., Gao, Y., Jiang, Z., Lv, J., Guo, H., & Li, S. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112809
Metadata
- Authors
- Anderberg, C., Li, H., Fredriksson, L., Andrae, J., Betsholtz, C., Li, X., Eriksson, U., & Pietras, K.
- Affiliations
- Ludwig Cancer Research (SE)
- 1Ludwig Institute for Cancer Research Ltd., Stockholm Branch, and
- Karolinska Institutet (SE)
- National Institutes of Health (US)
- Venue
- Cancer Research
- Published
- 2008-12-31
- Volume
- 69
- Issue
- 1
- Pages
- 369-378
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC2613547
- OpenAlex
- W2160108544
- Cited by
- 249
- References
- 49
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 6 · 2023: 16 · 2022: 10 · 2021: 10 · 2020: 15 · 2019: 12 · 2018: 19 · 2017: 17 · 2016: 16 · 2015: 21 · 2014: 18 · 2013: 15 · 2012: 12
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Cancer Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Vanderbilt University
- Cancerfonden
- Karolinska Institutet
- Vetenskapsrådet
- National Institutes of Health (Z99 EY999999)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- PDGF-C, paracrine signaling, cancer-associated fibroblasts, tumor microenvironment, tumor stroma, melanoma, PDGF receptor alpha, osteopontin, tumor growth, fibroblast recruitment, stromal support
- MeSH terms
- Animals, Fibroblasts, Humans, Lymphokines, Melanoma, Melanoma, Experimental, Mice, Inbred C57BL, Platelet-Derived Growth Factor, Skin Neoplasms, Signal Transduction, Stromal Cells, Receptor, Platelet-Derived Growth Factor alpha, NIH 3T3 Cells, Cell Line, Tumor, Cell Growth Processes, Mice, Osteopontin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
